Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ALMS
ALMS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ALMS News
Deep Track Capital Acquires Significant Stake in Alumis
6d ago
Fool
Deep Track Capital Acquires Significant Stake in Alumis
6d ago
NASDAQ.COM
Cormorant Asset Management Increases Alumis Stake to 4.37%
May 17 2026
Fool
Omega Fund Management Reduces Alumis Stake
May 16 2026
Fool
Healthcare Stocks Decline on Friday Afternoon
May 15 2026
Yahoo Finance
Alumis Reports Q1 2026 Revenue of $1.74M
May 14 2026
seekingalpha
ACT Capital Management Acquires Alumis Shares
May 10 2026
NASDAQ.COM
ACT Capital Management Acquires New Position in Alumis
May 10 2026
Fool
ACT Capital Management Acquires New Position in Alumis Worth $4.36 Million
May 10 2026
Yahoo Finance
Envudeucitinib Shows Strong Efficacy in Psoriasis Trials
Mar 28 2026
Newsfilter
ALUMIS' ENVUDEUCITINIB SHOWS PROMISING EARLY RESULTS IN SKIN CLEARANCE, QUALITY OF LIFE, AND PSORIASIS SYMPTOMS IN TWO PHASE 3 TRIALS, HIGHLIGHTING ITS POTENTIAL AS A TOP ORAL TREATMENT FOR PLAQUE PSORIASIS
Mar 28 2026
moomoo
Alumis Reports 2025 Fiscal Year Financial Results
Mar 19 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Feb 26 2026
Benzinga
Wall Street Analysts Adjust Ratings
Feb 25 2026
Benzinga
Wall Street Analysts Adjust Ratings
Feb 25 2026
Benzinga
BML Capital Management Fully Exits Alumis Stake
Feb 03 2026
Fool
Show More News
